Inflammaging and immunosenescence may drive colorectal cancer risk in older adults

Older adults face a higher risk of colorectal cancer, but why this happens is not fully clear. A recent narrative review looks at two aging processes: inflammaging and immunosenescence. These terms describe how the body's immune system changes as we get older. Inflammaging means low-level, constant inflammation, while immunosenescence means the immune system becomes weaker and less able to fight threats. The authors suggest these changes could be the hidden drivers behind cancer in the elderly. This review does not report specific numbers or patient counts because it summarizes existing knowledge rather than testing a new treatment. The evidence is currently based on understanding mechanisms, not hard trial data. We must be careful not to overstate what we know yet. The fundamental immunological mechanisms that underlie this risk remain incompletely understood. This gap in knowledge is a key limitation of the current research. However, the findings are still important for the future. They may guide future endeavors in biomarker discovery, prevention, and therapeutic intervention. Scientists hope this work will lead to better ways to find early signs of disease or stop it before it starts. Until more data is available, we should focus on these potential pathways without making bold claims about cures or specific drug benefits.